These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2068476)

  • 61. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical study on aztreonam in pediatrics].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections.
    Umaña MA; Odio CM; Castro E; Salas JL; McCracken GH
    Pediatr Infect Dis J; 1990 Mar; 9(3):175-80. PubMed ID: 2186351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
    Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
    Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Empiric antimicrobial therapy with aztreonam or ceftazidime in gram-negative septicemia.
    Lagast H; Klastersky J; Kains JP; van der Auwera P; Meunier F; Woussen F; Thijs JP
    Am J Med; 1986 May; 80(5C):79-84. PubMed ID: 3521272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL
    Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
    Knockaert DC; Dejaeger E; Nestor L; Verbist L; Pelemans W
    Age Ageing; 1991 Mar; 20(2):135-9. PubMed ID: 2053504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aztreonam activity, pharmacology, and clinical uses.
    Neu HC
    Am J Med; 1990 Mar; 88(3C):2S-6S; discussion 38S-42S. PubMed ID: 2180293
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
    Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
    J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [TBL] [Abstract][Full Text] [Related]  

  • 76. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.
    Gudiol F; Pallarés R; Ariza X; Fernández-Viladrich P; Rufi G; Liñares J
    J Antimicrob Chemother; 1986 May; 17(5):661-71. PubMed ID: 3722035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aztreonam in the treatment of gram-negative bacterial meningitis.
    Lentnek AL; Williams RR
    Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Empiric antibiotic use--aztreonam as a model.
    Levin S
    Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.